France tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 2.6% during the forecast period. The establishment of the Commission was more than an attempt to control the spread of tuberculosis across the France. It was hoped that successful management of the disease would result in a more robust French public health system. The Commission for the Prevention of Tuberculosis in France ended its activities in 1922 and its work was gradually handed over to French organizations. The annual mortality rate per 100,000 people from tuberculosis in France has decreased by 44.4% since 1990, an average of 1.9% a year. The mortality rate for tuberculosis has changed over time for men and women of specific age groups in France. France tuberculosis diagnostic and treatment market has been moderately contributing in the growth of the Europe tuberculosis diagnostic and treatment market due to high demand for TB drugs to improve the number of TB cases across the Europe.
Get Free Sample link @ https://www.omrglobal.com/request-sample/france-tuberculosis-diagnosis-treatment-market
France tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
A full report of France Tuberculosis Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/france-tuberculosis-diagnosis-treatment-market
- Market Coverage
- Market number available for – 2019-2025
- Base year- 2019
- Forecast period- 2020-2025
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
France Tuberculosis Diagnosis and Treatment Market by Drugs Type
- First Line Drugs
- Second Line Drugs
France Tuberculosis Diagnosis and Treatment Market by Diagnosis
- Laboratory Testing
- Nucleic Acid Amplification Test
- Mantoux Test
- Radiography
- Drug Susceptibility Testing
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co.
- BioMérieux SA
- HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Novartis AG
- Pifzer, Inc.
- Qiagen AG
- Sanofi S.A.
The Report Covers
- Comprehensive research methodology of the France Tuberculosis Diagnosis and Treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the France Tuberculosis Diagnosis and Treatment market.
- Insights about market determinants which are stimulating the France Tuberculosis Diagnosis and Treatment market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/france-tuberculosis-diagnosis-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
